What is the most appropriate technology to empower your research?
Next generation sequencing (NGS) for RNA (RNA-Seq) has advanced significantly over the last decade having gained popularity for investigating a wide variety of complex diseases at the transcriptome level. While RNA-Seq is an appropriate technology for de novo
discovery, it has significant limitations particularly for detecting low abundance transcripts and alternative splicing events, both of which require very deep sequencing. Increasing sequencing depth can result in dramatically increased costs and the requirement for considerable expertise in bioinformatics to effectively analyze data. The scientific community now widely acknowledges that there are specific applications best served by arrays and others by RNA-Seq. Additionally, many see an opportunity to harness the power of both technologies for expression studies. During this webinar, the speakers will:
- Discuss the pros and cons of each technology along with platform application suitability
- Demonstrate how arrays and RNA-Seq can be used to complement each other
- Explain how recently developed next generation arrays from Affymetrix can be used to overcome the limitations of RNA-Seq in both research and clinical settings
- Answer your questions live during the broadcast!